CAS: 182009-04-7
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Pemetrexed EP Impurity E (Pemetrexed Enantiomer) REF: 4Z-P-6852CAS: 182009-04-7 | - - - | To inquire | Tue 10 Dec 24 | |
(R)-Pemetrexed REF: TR-P945940CAS: 182009-04-7 | - - - | 1,472.00 € | Thu 16 Jan 25 | |
(2R)-2-{[4-(2-{2-amino-4-oxo-3H,4H,7H-pyrrolo[2,3-d]pyrimidin-5-yl}ethyl)phenyl]formamido}pentanedioic acid REF: 10-F546362CAS: 182009-04-7 | 95.0% | - - - | Discontinued product | |
(R)-Pemetrexed REF: 3D-HHA00904CAS: 182009-04-7 | Min. 95% | - - - | Discontinued product |
Pemetrexed EP Impurity E (Pemetrexed Enantiomer)
CAS:182009-04-7
Formula:
C20H21N5O6
Molecular weight:
427.42
Ref: 4Z-P-6852
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
(R)-Pemetrexed
Controlled ProductCAS:182009-04-7
Formula:
C20H21N5O6
Color and Shape:
Neat
Molecular weight:
427.411
Ref: TR-P945940
250mg | 1,472.00 € |
Estimated delivery in United States, on Thursday 16 Jan 2025
(2R)-2-{[4-(2-{2-amino-4-oxo-3H,4H,7H-pyrrolo[2,3-d]pyrimidin-5-yl}ethyl)phenyl]formamido}pentanedioic acid
CAS:182009-04-7
Purity:
95.0%
Molecular weight:
427.4169921875
Ref: 10-F546362
1g | Discontinued | Request information | |
250mg | Discontinued | Request information |
(R)-Pemetrexed
CAS:182009-04-7
(R)-Pemetrexed is an anticancer drug that inhibits the growth of cancer cells by blocking the …
Formula:
C20H21N5O6
Purity:
Min. 95%
Molecular weight:
427.4 g/mol
Ref: 3D-HHA00904
1mg | Discontinued | Request information | |
2mg | Discontinued | Request information | |
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
100mg | Discontinued | Request information |